| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/09680519060120010601 Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitansInstitute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland
Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland
Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University Graz, Graz, Austria
Section of Oral Microbiology, Institute of Odontology, UmeÅ University, UmeÅ, Sweden
Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland, pirkko.pussinen{at}helsinki.fi
An association between cardiovascular and periodontal disease may be due to lipopolysaccharide (LPS)-promoted release of inflammatory mediators, adverse alterations of the lipoprotein profile, and an imbalance in cholesterol homeostasis. Since periodontopathogenic potential differs between serotypes of a major periodontal pathogen, Actinobacillus actinomycetemcomitans, we studied the pro-atherogenic properties of LPS preparations from serotypes b and d strains on macrophages (RAW 264.7). A. actinomycetemcomitans LPS preparations induced a time-dependent release of tumor necrosis factor-
Key Words: Foam cell formation infection inflammation periodontitis RAW 264.7 macrophages SR-BI ABCA-1
|
(TNF-